The U.S. bariatric surgery devices market was valued at USD 0.73 billion in 2022 and is projected to reach USD 1.17 billion by 2030, growing at a CAGR of 6.1% between 2023 and 2030. The market is undergoing significant transformation due to various factors influencing the approach to obesity management and surgical treatments. The increasing prevalence of obesity, along with associated health risks such as diabetes and cardiovascular diseases, has been a major factor driving demand for bariatric procedures. Additionally, advancements in surgical technology have improved the accuracy and safety of these procedures, making them more appealing to both patients and healthcare providers. However, challenges such as high procedural costs and a shortage of skilled professionals persist. Furthermore, the introduction of weight loss medications, including FDA-approved drugs like Wegovy, Saxenda, Adipex, Qsymia, and Contrave, presents an alternative to surgery that could potentially impact market growth.
Click – https://www.marketsandata.com/industry-reports/united-states-bariatric-surgery-devices-market
Rising Obesity Rates and Related Health Conditions
The increasing number of obesity cases and associated health complications has been a key driver of market expansion. Obesity has become a major public health concern, contributing to chronic conditions such as hypertension, diabetes, and heart disease. Bariatric surgery has emerged as an effective solution for severe obesity and related health issues, leading to a growing demand for these procedures. Greater awareness of the health risks linked to obesity and the benefits of surgery has further fueled market growth. According to the American Society for Metabolic and Bariatric Surgery, more than 260,000 bariatric procedures were performed in 2021, with sleeve gastrectomy accounting for 58.16% of surgeries, Roux-en-Y gastric bypass (RYGB) making up 21.5%, and revisional bariatric procedures comprising 11.8%.
The Role of Insurance Coverage
Insurance coverage has been a critical factor in the expansion of the bariatric surgery devices market in the U.S. Recognizing obesity as a major health concern, many insurance providers now cover bariatric procedures, increasing accessibility for individuals suffering from severe obesity and related conditions. This broader insurance coverage has driven demand for surgical devices as healthcare facilities and professionals seek advanced tools to perform procedures more effectively. Prominent PPO insurance companies such as Aetna, Anthem Blue Cross Blue Shield, Cigna, Oscar, Tricare, and United Health Care now offer coverage for surgeries like gastric sleeve, gastric bypass, distal bypass, and lap-band removal.
Technological Innovations
Technological advancements are revolutionizing the bariatric surgery device market, with innovations aimed at improving surgical precision and patient outcomes. The growing adoption of robotic-assisted surgery has enhanced procedural accuracy and control for surgeons. Additionally, the increasing use of minimally invasive techniques, such as laparoscopic procedures, has helped reduce patient recovery time and post-surgical complications. Advances in surgical instruments, stapling devices, and staplers are further optimizing procedural effectiveness. These technological improvements are driving the market forward by making bariatric surgeries more efficient and ensuring better patient experiences and recovery times.
Sleeve Gastrectomy Leading Among Procedures
Among various bariatric surgical techniques, sleeve gastrectomy holds the largest market share, accounting for over half of all procedures performed. This minimally invasive surgery involves removing a portion of the stomach to create a smaller, tube-like structure, leading to reduced food intake and significant weight loss. In addition to sleeve gastrectomy, other procedures contributing to market growth include Roux-en-Y gastric bypass (RYGB), biliopancreatic diversion with duodenal switch (BPD/DS), single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S), adjustable gastric banding, robotic-assisted surgery, mini-gastric bypass, and noninvasive bariatric procedures. These diverse surgical options address different patient needs and conditions, demonstrating the dynamic evolution of the bariatric surgery market.
COVID-19 Impact
The COVID-19 pandemic significantly affected the U.S. bariatric surgery devices market. At the height of the pandemic, healthcare resources were redirected to manage COVID-19 cases, leading to delays and cancellations of elective procedures, including bariatric surgeries. Concerns over virus transmission and restrictions on non-urgent medical treatments temporarily reduced demand for bariatric surgical devices.
However, the pandemic also underscored the importance of addressing obesity, as individuals with obesity faced higher risks of severe COVID-19 complications. As healthcare systems adapted to pandemic-related challenges, the demand for bariatric surgeries began rebounding. The increased focus on weight management and the adoption of minimally invasive techniques—offering shorter hospital stays and faster recovery—are expected to contribute to market recovery and growth in the post-pandemic period.
United States Bariatric Surgery Devices Market: Report Insights
The “United States Bariatric Surgery Devices Market Assessment, Opportunities, and Forecast, 2016-2030F” report by Markets and Data offers an in-depth analysis of the market, including industry trends, challenges, and opportunities. The report covers market size, segmental analysis, growth projections, and the impact of COVID-19. Additionally, it profiles key market players, providing insights into their market share, business models, and competitive strategies.
Contact
Mr. Vivek Gupta5741 Cleveland street,Suite 120, VA beach, VA, USA 23462Tel: +1 (757) 343–3258Email: info@marketsandata.comWebsite: https://www.marketsandata.com
